Artificial intelligence is still an abstract concept in many areas, but already a reality in skin cancer prevention: The new FotoFinder Moleanalyzer pro brings artificial intelligence (AI) directly into the dermatologist's practice via the optional AI score and provides a variety of high quality functions such as analysis, comparison, checklist assessment and Second Opinion Service. Thus, it supports the physician whenever it comes to the assessment of atypical lesions.
The Moleanalyzer pro works with a deep learning algorithm. The human ability to learn from examples and experiences is transferred to the computer. Artificial neural networks enable complex machine learning that is similar to biological learning processes. In recent years, the neural network of Moleanalyzer pro has been trained with a large number of dermoscopic images - and the information whether these are benign or malignant lesions. The continuous "feeding" of the algorithm succeeds thanks to cooperation with doctors from all over the world!
The optional AI score is the perfect support for risk assessment of melanocytic and non-melanocytic skin lesions. Whether melanoma in situ or basal cell carcinoma, the accuracy is impressive!
To use the potential of artificial intelligence, you need Internet access and a "PRO" account in the FotoFinder Hub.
The AI score of the Moleanalyzer pro was evaluated by Prof. Dr. med. Holger Hänßle and Dr. med. Christine Fink at the Heidelberg University, Department of Dermatology. The corresponding study "Man against machine" proves the high accuracy of the score. Read all about the results of the study and the editorial by Professor Peter Soyer.
Moleanalyzer pro offers you the option to get a second opinion of experienced international dermoscopists. Prof. H. Peter Soyer, Prof. Andreas Blum or Prof. Rainer Hofmann-Wellenhof, for example, will give you valuable expert advice at the click of a mouse. All you need is Internet access and an account in the FotoFinder Hub.